CORRECTION article

Front. Oncol., 17 December 2020

Sec. Hematologic Malignancies

Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.632775

Corrigendum: Targeting Bcl-2 Proteins in Acute Myeloid Leukemia

  • 1. The First Central Clinical College of Tianjin Medical University, Tianjin, China

  • 2. Nankai University School of Medicine, Tianjin, China

  • 3. Department of Hematology, Tianjin First Central Hospital, Tianjin, China

Article metrics

View details

1k

Views

281

Downloads

In the published article, there was an error regarding the affiliation(s) for Mingfeng Zhao. Instead of “Mingfeng Zhao 1,3”, it should be “Mingfeng Zhao 3”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Summary

Keywords

B cell lymphoma 2, AML—acute myeloid leukemia, venetoclax (ABT-199), intrinsic apoptosis, Bcl-2 protein

Citation

Wei Y, Cao Y, Sun R, Cheng L, Xiong X, Jin X, He X, Lu W and Zhao M (2020) Corrigendum: Targeting Bcl-2 Proteins in Acute Myeloid Leukemia. Front. Oncol. 10:632775. doi: 10.3389/fonc.2020.632775

Received

24 November 2020

Accepted

25 November 2020

Published

17 December 2020

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

10 - 2020

Updates

Copyright

*Correspondence: Mingfeng Zhao,

This article was submitted to Hematologic Malignancies, a section of the journal Frontiers in Oncology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics